{"id":"https://openalex.org/W2316401213","doi":"https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","title":"Long-Term Safety Of Budesonide/formoterol Pressurized Metered-Dose Inhaler (PMDI) And Budesonide PMDI In African-American Patients With Asthma: Asthma Exacerbations And Adverse Events","display_name":"Long-Term Safety Of Budesonide/formoterol Pressurized Metered-Dose Inhaler (PMDI) And Budesonide PMDI In African-American Patients With Asthma: Asthma Exacerbations And Adverse Events","publication_year":2011,"publication_date":"2011-05-01","ids":{"openalex":"https://openalex.org/W2316401213","doi":"https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","mag":"2316401213"},"language":"en","primary_location":{"id":"doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","doi":"https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","is_oa":false,"landing_page_url":"https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"A31. OPTIMIZING THERAPEUTIC STRATEGIES IN AIRWAYS DISEASE","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044861254","display_name":"Randall W. Brown","orcid":"https://orcid.org/0000-0002-8093-991X","observed_orcids":["https://orcid.org/0000-0002-8093-991X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Randall W. Brown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111932060","display_name":"Tom Uryniak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tom Uryniak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013024827","display_name":"Kathy L. Lampl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathy L Lampl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1294","last_page":"A1294"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/budesonide-formoterol","display_name":"budesonide/formoterol","score":0.984000027179718},{"id":"https://openalex.org/keywords/budesonide","display_name":"budesonide","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pressurized-metered-dose-inhaler","display_name":"pressurized metered-dose inhaler","score":0.9449999928474426},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.6579999923706055},{"id":"https://openalex.org/keywords/asthma-exacerbations","display_name":"asthma exacerbations","score":0.9139999747276306},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9079999923706055},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.8939999938011169},{"id":"https://openalex.org/keywords/african-american-patients","display_name":"African American patients","score":0.9200000166893005},{"id":"https://openalex.org/keywords/racial-differences","display_name":"racial differences","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.8851726651191711},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.8052802085876465},{"id":"https://openalex.org/C2780667556","wikidata":"https://www.wikidata.org/wiki/Q16897784","display_name":"Metered-dose inhaler","level":4,"score":0.7524337768554688},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.747959315776825},{"id":"https://openalex.org/C2777450039","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Budesonide/formoterol","level":5,"score":0.7385720014572144},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7276875376701355},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.6906155347824097},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6655479073524475},{"id":"https://openalex.org/C2909082789","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma exacerbations","level":3,"score":0.4179239571094513},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3770643174648285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1475324034690857}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","doi":"https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","is_oa":false,"landing_page_url":"https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1294","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"A31. OPTIMIZING THERAPEUTIC STRATEGIES IN AIRWAYS DISEASE","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2332589773","https://openalex.org/W2003995989","https://openalex.org/W1991813083","https://openalex.org/W1990536820","https://openalex.org/W2019994715","https://openalex.org/W2317413253","https://openalex.org/W2316247974","https://openalex.org/W2067359064","https://openalex.org/W2072271497","https://openalex.org/W2316642373"],"abstract_inverted_index":null,"counts_by_year":[{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}